13-cis-retinoic acid competitively inhibits 3α-hydroxysteroid oxidation by retinol dehydrogenase RoDH-4: A mechanism for its anti-androgenic effects in sebaceous glands?

Academic Article


  • Retinol dehydrogenase-4 (RoDH-4) converts retinol and 13-cis-retinol to corresponding aldehydes in human liver and skin in the presence of NAD+. RoDH-4 also converts 3α-androstanediol and androsterone into dihydrotestosterone and androstanedione, which may stimulate sebum secretion. This oxidative 3α-hydroxysteroid dehydrogenase (3α-HSD) activity of RoDH-4 is competitively inhibited by retinol and 13-cis-retinol. Here, we further examine the substrate specificity of RoDH-4 and the inhibition of its 3α-HSD activity by retinoids. Recombinant RoDH-4 oxidized 3,4-didehydroretinol - a major form of vitamin A in the skin - to its corresponding aldehyde. 13-cis-retinoic acid (isotretinoin), 3,4-didehydroretinoic acid, and 3,4-didehydroretinol, but not all-trans-retinoic acid or the synthetic retinoids acitretin and adapalene, were potent competitive inhibitors of the oxidative 3α-HSD activity of RoDH-4, i.e., reduced the formation of dihydrotestosterone and androstandione in vitro. Extrapolated to the in vivo situation, this effect might explain the unique sebosuppressive effect of isotretinoin when treating acne. © 2003 Elsevier Science (USA). All rights reserved.
  • Digital Object Identifier (doi)

    Author List

  • Karlsson T; Vahlquist A; Kedishvili N; Törmä H
  • Start Page

  • 273
  • End Page

  • 278
  • Volume

  • 303
  • Issue

  • 1